patent/BR-PI0610907-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0610907-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-06
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
filingDate	2006-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef8631a2ed580f5799bfe8f88aed99c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da3154e8b4b54fd8a50ff00b46c36a50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74589d5599b06ceb5e3dabc5161a057b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6efe5df974530ceced1c4c36ad244cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_747da8b2f5214d124f4994485c71e30b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a70db64327b38c6e0dd67cc08b48d4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f739f8f3c3b4c0d30e9787899eccd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea303e014482ae07b7a15fcfd77097eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a6e5149de5c5fbaea5faa01bc0f0788
publicationDate	2008-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-PI0610907-A2
titleOfInvention	hydrolysable in vivo or pharmaceutically acceptable salt compound or precursors thereof, methods of treatment or prophylaxis of a disease or condition in which modulation of the mch1 receptor is beneficial and of treatment or prophylaxis of diseases, pharmaceutical composition, and, use of a compound
abstract	HYDROLYZABLE COMPOUND OR PRECURSORS OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, METHODS OF TREATMENT OR PROPHILAXY OF A DISEASE OR CONDITION IN WHICH MODULATION OF THE MCH1 RECEIVER IS EFFECTIVE, AND THE PROFESSION OF, OR COMPLEXING . Where R¹, D, R², A and Rü are as described in the report, pharmaceutically acceptable salts, methods of manufacture, pharmaceutical compositions containing them and methods for using them.
priorityDate	2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283

Total number of triples: 49.